Evidence map›Paper›PMID 37886970›Full record

ArticleCurrent issues in molecular biology2023

Association of

Krzysztof Maria Wilczyński, Aleksandra Auguściak-Duma, Aleksandra Stasik, Lena Cichoń, Alicja Kawalec, Małgorzata Janas-Kozik

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Krzysztof Maria WilczyńskiDepartment of Developmental Age Psychiatry and Psychotherapy, Medical University of Silesia, 40-061 Katowice, Poland.ORCID 0000-0002-8836-8568
Aleksandra Auguściak-DumaDepartment of Molecular Biology and Genetics, Medical University of Silesia, 40-061 Katowice, Poland.ORCID 0000-0001-5426-3277
Aleksandra StasikJohn Paul II Children's and Family Health Center in Sosnowiec sp. z o.o., Gabrieli Zapolskiej 3, 41-218 Sosnowiec, Poland.
Lena CichońDepartment of Developmental Age Psychiatry and Psychotherapy, Medical University of Silesia, 40-061 Katowice, Poland.
Alicja KawalecDepartment of Developmental Age Psychiatry and Psychotherapy, Medical University of Silesia, 40-061 Katowice, Poland.
Małgorzata Janas-KozikDepartment of Developmental Age Psychiatry and Psychotherapy, Medical University of Silesia, 40-061 Katowice, Poland.
Medical University of Silesia · PLInstitute of Occupational Medicine and Environmental Health · PL

Funding

Medical University of Silesia PCN-2-102/K1/K
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that affects social interactions, communication, and behavior. Although the predominant genetic predisposition to ASD seems beyond doubt, its exact nature remains unclear. In the context of social cognition disorders and the basis of ASD, the oxytocinergic and vasopresynergic systems arouse great interest among researchers. The aim of the present study was to analyze gene expression levels for oxytocin and vasopressin receptors, as well as CD38 protein and oxytocinase, in the context of the clinical picture of autism spectrum disorders. The study included 90 people, of whom 63 were diagnosed with ASD based on anamnesis, mental status testing, and the ADOS-2 protocol. The results obtained in the presented study indicate that the balance between the levels of expression of the CD38 gene and the oxytocinase gene plays a key role in the risk and clinical presentation of ASD. In a hypothetical scenario, an imbalance in the expression of CD38 and LNPEP could potentially lead to alterations in the concentrations of oxytocin and vasopressin. At the same time, the most frequently studied genes-AVPR1a and OXTR-seem to be at best of marginal importance for the risk of ASD.

Indexed as

autismexpressionoxytocin

Identifiers

PMID37886970
PMCPMC10604998
OpenAlexW4387671577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.